Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
about
Implantable defibrillators versus medical therapy for cardiac channelopathiesUse of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrestEuropean Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyImplantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerationsCatheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical reviewMitral Subvalvular Aneurysm in a Patient with Chagas Disease and Recurrent Episodes of Ventricular TachycardiaSubcutaneous implantable defibrillator: State-of-the art 2013.A Questionable Indication For ICD Extraction After Successful VT Ablation2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theIschaemic heart disease presenting as arrhythmiasPreventing sudden death and the use of prophylactic implanted defibrillatorsEpidemiology of ventricular tachyarrhythmia : Any changes in the past decades?Estimating the Risks and Benefits of Implantable Cardioverter Defibrillator Generator Replacement: A Systematic Review.Suitability for subcutaneous defibrillator implantation: results based on data from routine clinical practice.Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.Atrial tachyarrhythmias in primary and secondary prevention ICD recipients: clinical and prognostic data.REmote SUpervision to Decrease HospitaLization RaTe. Unified and integrated platform for data collected from devices manufactured by different companies: Design and rationale of the RESULT study.Distinct clinical features in the recipients of the implantable cardioverter defibrillator in Taiwan: a multicenter registry study.Impact of the multicenter automatic defibrillator implantation trial on clinical practice.Impact of the main implantable cardioverter-defibrillator trials for primary and secondary prevention in Italy: a survey of the national activity during the years 2001-2004.Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.Microvolt T-wave alternans as a predictor of mortality and severe arrhythmias in patients with left-ventricular dysfunction: a systematic review and meta-analysis.Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial.ICDs at higher age and clinical risk factors.Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator.Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.Impact of moderate to severe renal impairment on mortality and appropriate shocks in patients with implantable cardioverter defibrillatorsPerceptions of an implantable cardioverter-defibrillator: A qualitative study of families with a history of sudden life-threatening cardiac events and recommendations to improve care.Electrical storms in patients with an implantable cardioverter defibrillatorImprovements in 25 Years of Implantable Cardioverter Defibrillator Therapy.Predictors of implantable cardioverter-defibrillator use in patients with ischemic cardiomyopathy.Relevance of guideline-based ICD indications to clinical practice.Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects.Implantable cardioverter-defibrillators in arrhythmias: a rapid and systematic review of effectiveness.Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.Cost-effectiveness of automated external defibrillator deployment in selected public locations.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the
P2860
Q24186596-7CD07ED1-F358-4317-9B12-49C7F5F696EAQ24685115-EF23F591-F590-4177-9E58-F9AB3AB25106Q26796261-B45F7264-CAD9-4EA0-8F2C-8BAEFBD1FA60Q26852920-2F467F4C-2433-47DA-98F1-66B49D526E30Q27006486-F3243644-E5E1-42C5-9340-CA62E214AE91Q27316165-6A22B846-A78A-43DF-8095-88F8A6B9FBE4Q27691421-9EB21E6C-FA17-4165-A3D5-2489BDEA1924Q28082167-83DF6020-96AE-47DC-BE5B-65B3A5EA8DF5Q28087002-50D4ACFF-9748-4EF4-871F-3C72EC249203Q28191938-48A388CC-A967-407F-9685-8E1EB7CB72CFQ28200390-B37A0D4D-4A85-4E97-BFC3-B43FEA79F62AQ30234521-7640554C-A1CA-4B67-B863-ACECF3072D85Q30251798-D4F5E7EC-C1E9-49D9-B04A-63F872E13F6AQ30632380-EF391128-49F8-4B73-B859-076D01ECFC86Q31007688-632A21C3-7EBE-413E-A637-243A628AA0E7Q31016826-6E9E45CF-5141-43C2-B215-257954AEB4FEQ31085565-989297B8-1F7E-4431-BB9E-B0CCD538CE7AQ31151338-937F2756-2C69-4CAE-AFB2-9C64262D7699Q33150718-AD046C5D-BF17-4DE3-A674-DBBC2C025BBBQ33153560-9BF60616-4B7A-4E5B-864D-C3D9B4505E6CQ33154567-2A28A4F7-D3BB-4361-94C3-7BB7568F65C5Q33163845-24841719-474A-4132-A31E-B565C61C5C4FQ33403639-4C64F2B9-51BB-4A69-BABD-A3323C08FEA4Q33589930-536BEDC5-F362-4E83-A76C-E678F980C4D0Q33651346-E14C62EE-DBC3-47ED-B475-C2218094A28BQ33792627-B9F24D8C-BF78-463D-8F0C-82D271B834AEQ34068720-5F7F11C2-5902-4C2E-B185-D857B816BA44Q34069413-E6E42FB0-E59B-4A51-9360-0EA233D9C837Q34224601-67065571-20EA-43D4-981D-54F9218FD175Q34442569-B3BF66BE-1D87-46D4-85B5-4FCBBAC76025Q34463807-F3D3DC96-0D78-4470-8DCE-87B22B1B5FA9Q34474624-E14E7A90-0061-4CA4-9AA3-AD09ED6ABF60Q34491469-892586BD-A7B6-4321-90A8-37B0CD73A4CAQ34517911-07F2B6BA-8D90-4877-ABF6-9467D892841DQ34541882-C01D7B9A-EDAE-4E78-ADAD-BADF518367DDQ34544828-FE4DA85D-CE19-451A-BFA6-04ECE457250EQ34629096-9CDB2201-38D9-4564-AB79-B302BDDF99F9Q34723139-61B40AAF-E21A-421B-A1B2-64FE6A84C8BBQ34742249-D80B23DA-2D93-48A7-9BA5-674E6F1768ACQ34830023-9F96A2E3-6DFA-4B77-8240-193192A9C1F0
P2860
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Meta-analysis of the implantab ...... plantable Defibrillator Study.
@en
Meta-analysis of the implantab ...... plantable Defibrillator Study.
@nl
type
label
Meta-analysis of the implantab ...... plantable Defibrillator Study.
@en
Meta-analysis of the implantab ...... plantable Defibrillator Study.
@nl
prefLabel
Meta-analysis of the implantab ...... plantable Defibrillator Study.
@en
Meta-analysis of the implantab ...... plantable Defibrillator Study.
@nl
P2093
P921
P356
P1476
Meta-analysis of the implantab ...... mplantable Defibrillator Study
@en
P2093
Connolly SJ
Domanski M
Follmann D
Hallstrom AP
Roberts RS
P304
P356
10.1053/EUHJ.2000.2476
P577
2000-12-01T00:00:00Z